Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host

Transplant Infectious Disease

Volumn 8, Issue 3, 2006, Pages 128-139

  Wheat, L J ^a  

^a MIRAVISTA DIAGNOSTICS   (United States)

Author keywords

glucan; Antigen detection; Aspergillosis; Assays; Blastomycosis; Candidiasis; Coccidiodomycosis; Cryptococcosis; Galactomannan; Histoplasmosis; Immunocompromised host; Molecular diagnosis; Mycoses; Paracoccidiodomycosis; PCR; Penicilliosis marneffei

Indexed keywords

BETA GLUCAN;

ANTIBODY RESPONSE; ANTIGEN DETECTION; ASPERGILLOSIS; BLASTOMYCOSIS; CRYPTOCOCCOSIS; DIAGNOSTIC PROCEDURE; HISTOPLASMOSIS; IMMUNE DEFICIENCY; MYCOSIS; PENICILLIUM MARNEFFEI; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROLOGY; SOUTH AMERICAN BLASTOMYCOSIS;

ANTIGENS, FUNGAL; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES; POLYMERASE CHAIN REACTION; SEROLOGY;

EID: 33746989328     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00165.x     Document Type: Review

References (108)

1. CAILLOT D, COUAILLIER JF, BERNARD A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001: 19: 253-259.
2. WHEAT L. Rapid diagnosis of invasive aspergillosis by antigen detection. Transpl Infect Dis 2003: 5: 158-166.
3. MENNINK-KERSTEN MA, DONNELLY JP, VERWEIJ PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004: 4: 349-357.
4. WHEAT LJ. Galactomannan antigenemia detection for diagnosis of invasive aspergillosis, part I. Clin Microbiol Newslett 2005: 27: 51-57.
5. WHEAT LJ. Galactomannan antigenemia detection for diagnosis of invasive aspergillosis, part II. Clin Microbiol Newslett 2005: 27: 59-63.
6. MAERTENS J, THEUNISSEN K, VERBEKEN E, et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004: 126: 852-860.
7. KAWAZU M, KANDA Y, NANNYA Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1 → 3)-{beta}-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004: 42: 2733-2741.
8. MARR KA, BALAJEE SA, MCLAUGHLIN L, TABOURET M, BENTSEN C, WALSH TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004: 190: 641-649.
9. MARR KA, LAVERDIERE M, GUGEL A, LEISENRING W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005: 40: 1762-1769.
10. PAZOS C, PONTON J, PALACIO AD. Contribution of (1 → 3)-{beta}-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005: 43: 299-305.
11. WEISSER M, RAUSCH C, DROLL A, et al. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis 2005: 41: 1143-1149.
12. HORIGUCHI Y. [The performance of (1, 3)-beta-D-glucan and Aspergillus galactomannan measurement for early diagnosis of invasive aspergillosis in patients with hematological diseases.] Kansenshogaku Zasshi 2004: 78: 566-573.
13. BUCHHEIDT D, HUMMEL M, SCHLEIERMACHER D, et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004: 125: 196-202.
14. BRETAGNE S, COSTA JM, BART-DELABESSE E, DHéDIN N, RIEUX C, CORDONNIER C. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 1998: 26: 1407-1412.
15. PICKERING JW, SANT HW, BOWLES CAP, ROBERTS WL, WOODS GL. Evaluation of a (1 → 3)-{beta}-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005: 43: 5957-5962.
16. WHITE PL, LINTON CJ, PERRY MD, JOHNSON EM, BARNES RA. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 2006: 42: 479-486.
17. BART-DELABESSE E, BASILE M, AL JIJAKLI A, et al. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol 2005: 43: 5214-5220.
18. WALSH TJ, SHOHAM S, PETRAITIENE R, et al. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004: 42: 4744-4748.
19. EL SALEEBY CM, ALLISON KJ, KNAPP KM, WALSH TJ, HAYDEN RT. Discordant rise in galactomannan antigenemia in a patient with resolving aspergillosis, renal failure, and ongoing hemodialysis. J Clin Microbiol 2005: 43: 3560-3563.
20. MURASHIGE N, KAMI M, KISHI Y, FUJISAKI G, TANOSAKI R. False-positive results of Aspergillus enzyme-linked immunosorbent assays for a patient with gastrointestinal graft-versus-host disease taking a nutrient containing soybean protein. Clin Infect Dis 2005: 40: 333-334.
21. MENNINK-KERSTEN MA, KLONT RR, WARRIS A, OP DEN CAMP HJ, VERWEIJ PE. Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection. Lancet 2004: 363: 325-327.
22. MENNINK-KERSTEN MA, RUEGEBRINK D, KLONT RR, et al. Pifidobacterial lipoglycan as a new cause for false-positive Platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J Clin Microbiol 2005: 43: 3925-3931.
23. DALLE F, CHARLES PE, BLANC K, et al. Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J Clin Microbiol 2005: 43: 2929-2931.
24. SULAHIAN A, BOUTBOUL F, RIBAUD P, LEBLANC T, LACROIX C, DEROUIN F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001: 91: 311-318.
25. MAERTENS J, THEUNISSEN K, VERHOEF G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005: 41: 1242-1250.
26. KLONT RR, MENNINK-KERSTEN MA, VERWEIJ PE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis 2004: 39: 1467-1474.
27. BECKER MJ, LUGTENBURG EJ, CORNELISSEN JJ, VAN DER SC, HOOGSTEDEN HC, DE MARIE S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003: 121: 448-457.
28. MUSHER B, FREDRICKS D, LEISENRING W, BALAJEE SA, SMITH C, MARR KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004: 42: 5517-5522.
29. SANGUINETTI M, POSTERARO B, PAGANO L, et al. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 2003: 41: 3922-3925.
30. SIEMANN M, KOCH-DORFLER M. The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergillosis (IPA). Mycoses 2001: 44: 266-272.
31. KWAK EJ, HUSAIN S, OBMAN A, et al. Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004: 42: 435-438.
32. FORTUN J, MARTIN-DAVILA P, ALVAREZ ME, et al. and Ramon y Cajal Hospital's Liver Transplant Group. Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation 2001: 71: 145-149.
33. SCHMIDT S, BADEN LR, LOWRY C, MARTY FM. Usefulness of serum galactomannan assay for the diagnosis and management of invasive aspergillosis in lung transplant recipients (Abstract). ICAAC Poster M-160, December 16, 2006.
34. BOUTBOUL F, ALBERTI C, LEBLANC T, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis 2002: 34: 939-943.
35. ROHRLICH P, SARFATI J, MARIANI P, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996: 15: 232-237.
36. SALONEN J, LEHTONEN OP, TERASJARVI MR, NIKOSKELAINEN J. Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome. Scand J Infect Dis 2000: 32: 485-490.
37. MIYAZAKI T, KOHNO S, MITSUTAKE K, et al. Plasma (1→3)-β-D- glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol 1995: 33: 3115-3118.
38. YUASA K, GOTO H, IGUCHI M, OKAMURA T, IEKI R. Evaluation of the diagnostic value of the measurement of (1→3)- β-D-glucan in patients with pulmonary aspergillosis. Respiration 1996: 63: 78-83.
39. OBAYASHI T, YOSHIDA M, MORI T, et al. Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995: 345: 17-20.
40. ODABASI Z, MATTIUZZI G, ESTEY E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004: 39: 199-205.
41. KAMI M, FUKUI T, OGAWA S, et al. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 2001: 33: 1504-1512.
42. DIGBY J, KALBFLEISCH J, GLENN A, LARSEN A, BROWDER W, WILLIAMS D. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 2003: 10: 882-885.
43. COSTA C, COSTA JM, DESTERKE C, BOTTEREL F, CORDONNIER C, BRETAGNE S. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microbiol 2002: 40: 2224-2227.
44. DONNELLY JP. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still aways to go. Clin Infect Dis 2006: 42: 487-489.
45. CHALLIER S, BOYER S, ABACHIN E, BERCHE P. Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis. J Clin Microbiol 2004: 42: 844-846.
46. OSTROSKY-ZEICHNER L, KONTOYIANNIS D, RAFFALLI J, et al. International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia. Eur J Clin Microbiol Infect Dis 2005: 24: 654-661.
47. MORRELL M, FRASER VJ, KOLLEF MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005: 49: 3640-3645.
48. GADE W, HINNEFELD SW, BABCOCK LS, et al. Comparison of the Premier cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens. J Clin Microbiol 1991: 29: 1616-1619.
49. WHEAT LJ. Current diagnosis of histoplasmosis. Trends Microbiol 2003: 11: 488-494.
50. DURKIN M, WITT J, LEMONTE A, WHEAT B, CONNOLLY P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004: 42: 4873-4875.
51. WEINER MH. Antigenemia detected in human coccidioidomycosis. J Clin Microbiol 1983: 18: 136-142.
52. KAUFMAN L, STANDARD PG, JALBERT M, KANTIPONG P, LIMPAKARNJANARAT K, MASTRO TD. Diagnostic antigenemia tests for penicilliosis marneffei. J Clin Microbiol 1996: 34: 2503-2505.
53. WONG SS, WONG KH, HUI WT, LEE SS, et al. Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol 2001: 39: 4535-4540.
54. DESAKORN V, SMITH MD, WALSH AL, et al. Diagnosis of Penicillium marneffei infection by quantitation of urinary antigen by using an enzyme immunoassay. J Clin Microbiol 1999: 37: 117-121.
55. DESAKORN V, SIMPSON AJ, WUTHIEKANUN V, et al. Development and evaluation of rapid urinary antigen detection tests for diagnosis of penicilliosis marneffei. J Clin Microbiol 2002: 40: 3179-3183.
56. PANICHAKUL T, CHAWENGKIRTTIKUL R, CHAIYAROJ SC, SIRISINHA S. Development of a monoclonal antibody-based enzyme-linked immunosorbent assay for the diagnosis of Penicillium marneffei infection. Am J Trop Med Hyg 2002: 67: 443-447.
57. CHAIYAROJ SC, CHAWENGKIRTTIKUL R, SIRISINHA S, WATKINS P, SRINOULPRASERT Y. Antigen detection assay for identification of Penicillium marneffei infection. J Clin Microbiol 2003: 41: 432-434.
58. MARQUES DA SILVA SH, MATTOS GROSSO D, LOPES JD, et al. Detection of Paracoccidioides brasiliensis gp70 circulating antigen and follow-up of patients undergoing antimycotic therapy. J Clin Microbiol 2004: 42: 4480-4486.
59. MARQUES DA SILVA SH, COLOMBO AL, BLOTTA MH, LOPES JD, QUEIROZ-TELLES F, PIRES DC. Detection of circulating gp43 antigen in serum, cerebrospinal fluid, and bronchoalveolar lavage fluid of patients with paracoccidioidomycosis. J Clin Microbiol 2003: 41: 3675-3680.
60. FELDMESSER M, HARRIS C, REICHBERG S, KHAN S, CASADEVALL A. Serum cryptococcal antigen in patients with AIDS. Clin Infect Dis 1996: 23: 827-830.
61. MEYOHAS MC, ROUX P, BOLLENS D, et al. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis 1995: 21: 628-633.
62. BAUGHMAN RP, RHODES JC, DOHN MN, HENDERSON H, FRAME PT. Detection of cryptococcal antigen in bronchoalveolar lavage fluid: a prospective study of diagnostic utility. Am Rev Respir Dis 1992: 145: 1226-1229.
63. YOUNG EJ, HIRSH DD, FAINSTEIN V, WILLIAMS TW. Pleural effusions due to Cryptococcus neoformans: a review of the literature and report of two cases with cryptococcal antigen determinations. Am Rev Respir Dis 1980: 121: 743-747.
64. POWDERLY WG, CLOUD GA, DISMUKES WE, SAAG MS. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis 1994: 18: 789-792.
65. LU H, ZHOU Y, YIN Y, PAN X, WENG X. Cryptococcal antigen test revisited: significance for cryptococcal meningitis therapy monitoring in a tertiary Chinese hospital. J Clin Microbiol 2005: 43: 2989-2990.
66. WHEAT LJ, CONNOLLY-STRINGFIELD P, WILLIAMS B, et al. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. Am Rev Respir Dis 1992: 145: 1421-1424.
67. WHEAT LJ, MUSIAL CE, JENNY-AVITAL E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 2005: 40: 844-852.
68. WHEAT LJ, CONNOLLY P, DURKIN M, et al. False-positive Histoplasma antigenemia caused by antithymocyte globulin antibodies. Transpl Infect Dis 2004: 6: 23-27.
69. WHEAT LJ, CONNOLLY-STRINGFIELD P, BLAIR R, CONNOLLY K, GARRINGER T, KATZ BP. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med 1991: 115: 936-941.
70. WILLIAMS B, FOJTASEK M, CONNOLLY-STRINGFIELD P, WHEAT J. Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind. Arch Pathol Lab Med 1994: 118: 1205-1208.
71. TOBON AM, AGUDELO CA, ROSERO DS, et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg 2005: 73: 576-582.
72. SMITH CD, FURCOLOW ML, HULKER P. Effect of immunosuppressants on dogs exposed two and one-half years previously to Blastomyces dermatitidis. Am J Epidemiol 1976: 104: 299-305.
73. VAIL GM, YOUNG RS, WHEAT LJ, FILO RS, CORNETTA K, GOLDMAN M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002: 4: 148-151.
74. WHEAT LJ. Histoplasmosis in Indianapolis. Clin Infect Dis 1992: 14 (Suppl 1): S91-S99.
75. WHEAT LJ, KOHLER RB, FRENCH ML, et al. Immunoglobulin M and G histoplasmal antibody response in histoplasmosis. Am Rev Respir Dis 1983: 128: 65-70.
76. ZIMMERMAN SE, FRENCH MLV, KLEIMAN MB, WHEAT LJ. Evaluation of an enzyme-linked immunosorbent assay that uses ferrous metal beads for determination of antihistoplasmal immunoglobulins G and M. J Clin Microbiol 1990: 28: 59-64.
77. SEKHON AS, KAUFMAN L, KOBAYASHI GS, MOLEDINA N, JALBERT M, NOTENBOOM RH. Comparative evaluation of the Premier enzyme immunoassay, micro-immunodiffusion and complement fixation tests for the detection of Histoplasma capsulatum var. capsulatum antibodies. Mycoses 1994: 37: 313-316.
78. WHEAT LJ, FRENCH MLV. The diagnostic approach in histoplasmosis. Immunol Allergy Pract V 1983: 9: 19-28.
79. BIALEK R, FEUCHT A, AEPINUS C, et al. Evaluation of two nested PCR assays for detection of Histoplasma capsulatum DNA in human tissue. J Clin Microbiol 2002: 40: 1644-1647
80. TANG YW, LI H, DURKIN MM, et al. Urine polymerase chain reaction is not as sensitive as urine antigen for the diagnosis of disseminated histoplasmosis. Diagn Microbiol Infect Dis 2006: 54: 283-287.
81. KLEIN BS, KURITSKY JN, CHAPPELL WA, et al. Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis. Am Rev Respir Dis 1986: 133: 144-148.
82. KLEIN BS, VERGERONT JM, KAUFMAN L, et al. Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin. J Infect Dis 1987: 155: 262-268.
83. BRADSHER RW, PAPPAS PG. Detection of specific antibodies in human blastomycosis by enzyme immunoassay. South Med J 1995: 88: 1256-1259.
84. SEKHON AS, KAUFMAN L, KOBAYASHI GS, MOLEDINA NH, JALBERT M. The value of the Premier enzyme immunoassay for diagnosing Blastomyces dermatitidis infections. J Med Vet Mycol 1995: 33: 123-125.
85. SOUFLERIS AJ, KLEIN BS, COURTNEY BT, PROCTOR ME, JONES JM. Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents. Clin Infect Dis 1994: 19: 87-92.
86. GALGIANI JN, DUGGER KO, ITO JI, WIEDEN MA. Antigenemia in primary coccidioidomycosis. Am J Trop Med Hyg 1984: 33: 645-649.
87. GALGIANI JN, GRACE GM, LUNDERGAN LL. New serologic tests for early detection of coccidioidomycosis. J Infect Dis 1991: 163: 671-674.
88. PAPPAGIANIS D, LEVINE HB. The present status of vaccination against coccidioidomycosis in man. Am J Epidemiol 1975: 102: 30-41.
89. BLAIR JE. Coccidioidomycosis in liver transplantation. Liver Transpl 2005: 12: 31-39.
90. KAUFMAN L, SEKHON AS, MOLEDINA N, JALBERT M, PAPPAGIANIS D. Comparative evaluation of commercial Premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies. J Clin Microbiol 1995: 33: 618-619.
91. ZARTARIAN M, PETERSON EM, DE LA MAZA LM. Detection of antibodies to Coccidioides immitis by enzyme immunoassay. Am J Clin Pathol 1997: 107: 148-153.
92. YU JJ, KIRKLAND TN, HALL LK, et al. Characterization of a serodiagnostic complement fixation antigen of Coccidioides posadasii expressed in the nonpathogenic fungus Uncinocarpus reesii. J Clin Microbiol 2005: 43: 5462-5469.
93. WOODS CW, MCRILL C, PLIKAYTIS BD, et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis 2000: 181: 1428-1434.
94. AMPEL NM. Coccidioidomycosis in persons infected with HIV type 1. Clin Infect Dis 2005: 41: 1174-1178.
95. BLAIR JE, LOGAN JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001: 33: 1536-1544.
96. SINGH VR, SMITH DK, LAWERENCE J, et al. Coccidioidomycosis in patients infected with human immunodeficiency virus: review of 91 cases at a single institution. Clin Infect Dis 1996: 23: 563-568.
97. SAROSI GA, LAWRENCE JP, SMITH DK, THOMAS A, HOBOHM DW, KELLEY PC. Rapid diagnostic evaluation of bronchial washings in patients with suspected coccidioidomycosis. Semin Respir Infect 2001: 16: 238-241.
98. PETERSEN LR, MARSHALL SL, BARTON-DICKSON C, et al. Coccidioidomycosis among workers at an archeological site, northeastern Utah. Emerg Infect Dis 2004: 10: 637-642.
99. SMITH CE, SAITO MT, BEARD RR, MCFADDEN RK, WHEATLAKE RC, EDDIE BU. Serological tests in the diagnosis and prognosis of coccidioidomycosis. Am J Hygiene 1950: 52: 1-21.
100. PAPPAGIANIS D. Serologic studies in coccidioidomycosis. Semin Respir Infect 2001: 16: 242-250.
101. BOUZA E, DREYER JS, HEWITT WL, MEYER RD. Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine (Baltimore) 1981: 60: 139-172.
102. JOHNSON RH, EINSTEIN HE. Coccidioidal meningitis. Clin Infect Dis 2006: 42: 103-107.
103. FREITAS-DA-SILVA G, ROQUE-BARREIRA MC. Antigenemia in paracoccidioidomycosis. J Clin Microbiol 1992: 30: 381-385.
104. MARQUES DA SILVA SH, QUEIROZ-TELLES F, COLOMBO AL, BLOTTA MH, LOPES JD, PIRES DC. Monitoring gp43 antigenemia in paracoccidioidomycosis patients during therapy. J Clin Microbiol 2004: 42: 2419-2424.
105. SALINA MA, SHIKANAI-YASUDA MA, MENDES RP, BARRAVIERA B, GIANNINI MJ. Detection of circulating Paracoccidioides brasiliensis antigen in urine of paracoccidioidomycosis patients before and during treatment. J Clin Microbiol 1998: 36: 1723-1728.
106. GOMEZ BL, FIGUEROA JI, HAMILTON AJ, ROBLEDO MA, HAY RJ, RESTREPO A. Use of monoclonal antibodies in diagnosis of paracoccidioidomycosis: new strategies for detection of circulating antigens. J Clin Microbiol 1997: 35: 3278-3283.
107. ALBUQUERQUE CF, DA SILVA SH, CAMARGO ZP. Improvement of the specificity of an enzyme-linked immunosorbent assay for diagnosis of paracoccidioidomycosis. J Clin Microbiol 2005: 43: 1944-1946.
108. CAO L, CHAN KM, CHEN D, et al. Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients. J Clin Microbiol 1999: 37: 981-986.